Travere Therapeutics, Inc. (TVTX) Profit Margins
Over the twelve months to 2026-06-30, Travere Therapeutics, Inc. (TVTX) had operating margin -6.8%, net margin -7.4%, free cash flow margin 15.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TVTXTravere Therapeutics, Inc.Follow TVTX — free
—
Price chart with a free account
- Market cap
- 4.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 96.6% | 97.0% | 96.9% | 97.1% | 96.0% | 92.1% | 96.7% | 97.9% | — | |
| Operating margin | -48.7% | -78.3% | -88.8% | -151.3% | -292.2% | -267.2% | -138.9% | -12.8% | -6.8% | |
| Net margin | -62.5% | -83.5% | -85.4% | -136.6% | -254.4% | -76.7% | -137.9% | -5.2% | -7.4% | |
| FCF margin | -15.6% | -33.3% | -25.0% | -15.1% | -170.4% | -193.3% | -101.8% | 7.7% | 15.7% |
USD millions · SEC XBRL
Travere Therapeutics, Inc. — questions
- What is Travere Therapeutics, Inc.'s operating margin?
- -6.8% over the twelve months to 2026-06-30.
- What is Travere Therapeutics, Inc.'s net profit margin?
- -7.4% over the twelve months to 2026-06-30.
Every figure on this page comes from Travere Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.